RETRACTED ARTICLE: Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut
- 24 March 2007
- journal article
- retracted article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (5) , 880-893
- https://doi.org/10.1007/s00134-007-0595-1
Abstract
This study investigated the effects of TDZD-8, a potent and selective GSK-3β inhibitor, on tissue injury caused by ischaemia/reperfusion (I/R) of the gut.Keywords
This publication has 36 references indexed in Scilit:
- Inhibition of glycogen synthase kinase‐3β attenuates the development of carrageenan‐induced lung injury in miceBritish Journal of Pharmacology, 2006
- Glycogen Synthase Kinase-3β Inhibition Reduces Secondary Damage in Experimental Spinal Cord TraumaThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase‐3βBritish Journal of Pharmacology, 2006
- GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*Critical Care Medicine, 2005
- EFFECTS OF HYPERICUM PERFORATUM EXTRACT IN A RAT MODEL OF ISCHEMIA AND REPERFUSION INJURYShock, 2005
- Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in miceLaboratory Investigation, 2004
- Genetic Deletion of Glycogen Synthase Kinase-3β Abrogates Activation of IκBα Kinase, JNK, Akt, and p44/p42 MAPK but Potentiates Apoptosis Induced by Tumor Necrosis FactorJournal of Biological Chemistry, 2004
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumPublished by Elsevier ,2002
- Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusionBritish Journal of Pharmacology, 2001
- Pharmacology of the Endothelium in Ischemia-Reperfusion and Circulatory ShockAnnual Review of Pharmacology and Toxicology, 1993